Dyne Therapeutics (DYN) Non-Current Assets (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Non-Current Assets data on file, last reported at $58.9 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 86.64% year-over-year to $58.9 million in Q1 2026; TTM through Mar 2026 was $182.3 million, a 40.75% increase from a year earlier, with the FY2025 full-year figure at $31.2 million, down 2.36% from the prior year.
• Non-Current Assets for Q1 2026 stood at $58.9 million, up from $31.2 million in the prior quarter.
• Over the last five years, Non-Current Assets for DYN reached as high as $60.8 million in Q3 2025 and fell as low as $31.0 million in Q2 2025.
• Historically, Non-Current Assets has averaged $39.0 million across 5 years, with a median of $37.0 million in 2023.
• Across the five-year window, Non-Current Assets surged 833.05% in 2022 and declined 13.42% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $40.7 million in 2022, then declined by 12.33% to $35.7 million in 2023, then declined by 10.51% to $32.0 million in 2024, then slipped by 2.36% to $31.2 million in 2025, then jumped by 88.86% to $58.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $58.9 million in Q1 2026, $31.2 million in Q4 2025, and $60.8 million in Q3 2025.